Qiagen N.V. (QGEN): $51.42

0.18 (+0.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add QGEN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

Qiagen Nv (QGEN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Qiagen Nv.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
16 $66 $50 $57.59 $51.34 12.17%

The Trend in the Analyst Price Target


Over the past 55 days, QGEN's average price target has gone up $1.09.

QGEN reports an average of 12.46% for its upside potential over the past 168 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-25 16 66.00 50 57.59 47.25 21.88%
2020-11-18 16 66.00 50 57.66 46.55 23.87%
2020-11-11 16 66.00 50 57.67 46.51 23.99%
2020-10-29 16 66.00 50 57.54 47.60 20.88%
2020-10-01 15 66.00 44 56.50 52.70 7.21%
2020-09-23 16 66.00 44 56.38 50.73 11.14%
2020-09-16 16 66.00 44 56.40 50.10 12.57%
2020-09-03 16 66.00 44 55.47 46.98 18.07%
2020-08-26 16 66.00 44 55.55 52.05 6.72%
2020-08-19 16 60.00 44 53.15 52.42 1.39%
2020-08-15 14 60.00 44 51.46 49.45 4.06%
2020-08-06 15 50.43 32 45.83 46.87 -2.22%
2020-07-22 15 49.15 32 44.46 NA NA%
2020-07-16 15 49.00 32 43.47 NA NA%
2020-07-11 14 44.01 32 41.84 NA NA%
2020-07-01 14 44.00 32 41.14 NA NA%
2020-06-24 13 43.00 32 40.87 NA NA%
2020-06-17 13 43.00 32 40.81 NA NA%
2020-06-13 13 43.00 32 40.79 NA NA%
2020-06-10 13 43.00 32 40.82 NA NA%

QGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


QGEN's average broker recommendation rating improved by 0.49 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for QGEN as an investment opportunity.

  • QGEN has a higher number of analysts covering the stock than 87.95% of all US stocks.
  • Qiagen Nv's upside potential (average analyst target price relative to current price) is higher than 11.55% of Pharmaceutical Products stocks.
  • Qiagen Nv's average analyst price target is greater than 82.74% of Pharmaceutical Products stocks.
  • The variance in analysts' estimates of QGEN is less than 70.97% of stocks in the large market cap category.

Make investment decisions regarding QGEN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.781 seconds.